MRKR

Marker Therapeutics, Inc.$1.15-0.02 (-1.54%)

Prev Close$1.17·MCap$15.9M·P/E—·Vol10.2K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$0.00

◆

Net Activity

Net Buyer

$0.00

●

Active Insiders

last 12 mo

MRKR Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Dec 26, 2024	ELMS STEVE	Director	Buy	11,085	$3.20	$35.5K	325,370
Dec 23, 2024	New Enterprise Associates 16, L.P.		Buy	554,250	$3.20	$1.77M5.1% OS	1,625,678+52%
Jun 8, 2023	Eansor Norman David	Director	Buy	14,285	$17.50	$250.0K	16,713+588%
May 20, 2021	Wasserman Frederick Gerald	Director	Buy	10,000	$2.41	$24.1K	52,565
Mar 18, 2021	ELMS STEVE	Director	Buy	1,142,857	$1.75	$2.00M10.6% OS	3,142,857+57%
Mar 18, 2021	Hoang Peter L.	President and CEO	Buy	142,857	$1.75	$250.0K1.3% OS	332,568+75%
Mar 18, 2021	Vera Juan	Chief Development Officer	Buy	571,428	$1.75	$1000.0K5.3% OS	2,564,487+29%
Mar 18, 2021	Walker Paul Edward	10% Owner	Buy	5,714,285	$1.75	$10.00M52.9% OS	10,714,285+114%
Mar 18, 2021	Wilson John Robert	Director	Buy	1,714,285	$1.75	$3.00M15.9% OS	7,799,350+28%

The following table shows recent insider purchases of Marker Therapeutics, Inc. (MRKR) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Dec 26, 2024	ELMS STEVE	Director	Buy	11,085	$3.20	$35.5K	325,370
Dec 23, 2024	New Enterprise Associates 16, L.P.		Buy	554,250	$3.20	$1.77M5.1% OS	1,625,678+52%
Jun 8, 2023	Eansor Norman David	Director	Buy	14,285	$17.50	$250.0K	16,713+588%
May 20, 2021	Wasserman Frederick Gerald	Director	Buy	10,000	$2.41	$24.1K	52,565
Mar 18, 2021	ELMS STEVE	Director	Buy	1,142,857	$1.75	$2.00M10.6% OS	3,142,857+57%
Mar 18, 2021	Hoang Peter L.	President and CEO	Buy	142,857	$1.75	$250.0K1.3% OS	332,568+75%
Mar 18, 2021	Vera Juan	Chief Development Officer	Buy	571,428	$1.75	$1000.0K5.3% OS	2,564,487+29%
Mar 18, 2021	Walker Paul Edward	10% Owner	Buy	5,714,285	$1.75	$10.00M52.9% OS	10,714,285+114%
Mar 18, 2021	Wilson John Robert	Director	Buy	1,714,285	$1.75	$3.00M15.9% OS	7,799,350+28%